CVRx
Austin, US · 4 known investors
CVRx develops Barostim, an implantable medical device that uses baroreceptor activation to treat heart failure patients and improve their functional capacity and quality of life.
BiotechHealthtechMedical Devices
Investors · 4
In the news
- CVRx enables first commercial Barostim implant in Washington state for heart failure treatmenttradersunion.com · 2026
- CVRx - 2026 Funding Rounds & List of Investors - Tracxntracxn.com · 2021
- News release: CVRx® Raises $50 Million in New Equity Financing - CVRxbarostim.com · 2020
- CVRx's $93 million financing tops recent funding news in Minneapolishoodline.com · 2019
- CVRx Raises Additional $12M in Series F Financing - FinSMEsfinsmes.com · 2013
- CVRx raises $29.6M for hypertension device | Fierce Biotechfiercebiotech.com · 2013